Drug Shortage Report for GENTAMICIN(E)

Last updated on 2018-09-05 History
Report ID 58562
Drug Identification Number 02082152
Brand name GENTAMICIN(E) 80MG LIQ IV 1.6MG/ML
Common or Proper name Gentamicin 80mg in 0.9% Sodium Chloride Injection
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) GENTAMICIN
Strength(s) 1.6MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50mL
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-08-20
Actual start date 2018-08-20
Estimated end date 2018-09-04
Actual end date 2018-09-04
Shortage status Resolved
Updated date 2018-09-05
Company comments Please consult your hospital pharmacy for acceptable clinical alternatives. Alternative dose of premixed gentamcin available - 100mg Gentamicin in 100ML 0.9% Sodium Chloride (JB0863).
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-09-05 English Compare
v9 2018-09-04 French Compare
v8 2018-09-04 English Compare
v7 2018-08-29 French Compare
v6 2018-08-29 English Compare
v5 2018-08-29 French Compare
v4 2018-08-29 English Compare
v3 2018-08-21 English Compare
v2 2018-08-20 French Compare
v1 2018-08-20 English Compare

Showing 1 to 10 of 10